Welcome to our dedicated page for CARECLOUD news (Ticker: CCLDO), a resource for investors and traders seeking the latest updates and insights on CARECLOUD stock.
CareCloud Inc (CCLDO) delivers cloud-based healthcare technology solutions that power high-growth medical practices through innovative EHR systems, practice management tools, and telehealth platforms. This dedicated news hub provides investors and industry professionals with timely updates on the company’s operational milestones, financial performance, and strategic initiatives.
Access authoritative reporting on CareCloud’s latest developments including quarterly earnings, product enhancements, leadership changes, and strategic partnerships. Our curated collection ensures you stay informed about critical updates affecting this healthcare IT innovator’s market position and service offerings.
Key focus areas include advancements in CareCloud’s revenue cycle management solutions, expansions of its telehealth capabilities, and developments in healthcare data analytics. All content is verified through primary sources to maintain accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined access to CareCloud’s official communications and third-party analyses. Regularly updated to reflect new developments in cloud-based healthcare technology and corporate strategy.
CareCloud (Nasdaq: CCLD / CCLDO) announced a formal plan to satisfy 14 months of unpaid dividends on its 8.75% Series B cumulative preferred stock by issuing double monthly payments starting with the January 2026 dividend (record date Jan 31, 2026; payment expected mid‑February 2026).
The arrears total approximately $3.9 million or $2.55 per share. Regular monthly dividends were fully reinstated in January 2025. The company says it will use internally generated cash flow (no common dilution) and expects arrears to be fully paid by the end of Q1 2027, while reserving the right to adjust timings for unforeseen circumstances.
CareCloud (Nasdaq: CCLD) reported third quarter 2025 results and raised full-year revenue guidance to $117–$119 million (previously $111–$114M). Q3 revenue was $31.1 million, up 9% year-over-year, marking six consecutive quarters of positive GAAP net income. Q3 GAAP net income was $3.1 million and adjusted EBITDA was $7.7 million (up 13% YoY). Nine-month revenue was $86.1 million (+4% YoY) and YTD adjusted EBITDA was $19.9 million. The company completed the Medsphere acquisition for a total purchase price of $16.5 million, reduced line-of-credit borrowings to $4.9 million, and launched an AI Center of Excellence to scale generative AI initiatives.
CareCloud (Nasdaq: CCLD) will present at the ThinkEquity Conference on October 30, 2025 at the Mandarin Oriental, New York City. The company's presentation is scheduled for 4:00 p.m. ET in the Lotus Suite East and will focus on AI innovation and its overall growth strategy.
CareCloud will also highlight four year-to-date transactions, including the Medsphere acquisition and the addition of HFMA’s MAP App, which the company says expanded its capabilities and client reach.
CareCloud (Nasdaq: CCLD) will present at the 2025 Maxim Growth Summit on October 22–23, 2025 at the Hard Rock Hotel New York City.
Presentation will highlight recent M&A activity (four transactions year‑to‑date, including the Medsphere acquisition in late August and the HFMA MAP App acquisition earlier this month), the Company’s AI roadmap and AI Center of Excellence scaling toward ~500 AI professionals, raised 2025 revenue guidance to $116–$118 million, positive free cash flow, resumption of preferred dividends, and inclusion in the Russell Microcap Index.
CareCloud (Nasdaq: CCLD) will release third quarter 2025 financial results for the period ended September 30, 2025 before the market opens on Thursday, November 6, 2025. A conference call for investors is scheduled for 8:30 a.m. Eastern Time the same day. A live webcast and presentation slides will be available at ir.carecloud.com/events; an audio-only option is available via dial-in numbers. A replay and slides will be posted roughly three hours after the call at the same link.
CareCloud (Nasdaq: CCLD, CCLDO) announced monthly cash dividends for its 8.75% Series A and Series B cumulative perpetual preferred shares for October, November and December 2025.
Key facts: monthly dividend per share $0.18229 for each series; Series A holders receive an additional payment tied to a prior 11% rate that equals $0.04688 (Oct), $0.01719 (Nov) and $0.00 (Dec); ex-dividend and record dates are the last day of each month (Oct 31, Nov 30, Dec 31, 2025); payment dates are Nov 17, 2025, Dec 15, 2025 and Jan 15, 2026.
Dividends are cumulative, calculated at 8.75% per annum on the $25 liquidation preference (equivalent to $2.1875 per annum per share). Previously converted Series A holders who converted on March 6, 2025 are not eligible for these payments.
CareCloud (NASDAQ: CCLD) has announced a definitive agreement to acquire HFMA's MAP App, a leading hospital benchmarking tool, with the deal set to close on October 1, 2025. The acquisition includes a long-term joint marketing agreement with the Healthcare Financial Management Association (HFMA).
MAP App, developed by HFMA and used by top hospitals nationwide, specializes in benchmarking and measuring revenue cycle management performance. CareCloud plans to enhance the tool's capabilities with AI-driven insights through its AI Center of Excellence, building on synergies from its recent Medsphere hospital IT business acquisition.
The partnership aims to expand MAP App's reach and capabilities while leveraging HFMA's network of 140,000 members. The acquisition is not expected to have a material financial impact on CareCloud in 2025.
CareCloud (NASDAQ: CCLD) has unveiled Marketware, a physician relationship management and analytics platform acquired through its recent Medsphere acquisition. The platform helps hospitals strengthen physician alignment, optimize referral networks, and drive measurable growth.
Marketware's key features include tracking referral patterns, reducing network leakage, and providing actionable intelligence through interactive dashboards. The platform is being integrated with CareCloud's AI Center of Excellence, revenue cycle management tools, and inpatient EHR solutions.
A live demonstration of Marketware is scheduled for October 8, 2025, at 1:00 PM ET, where hospitals can explore the platform's capabilities and learn about CareCloud's growth vision.
CareCloud (NASDAQ: CCLD) has secured a new $10 million credit facility with Provident Bank, with approximately $8.3 million drawn at closing to support the recent Medsphere Systems Corporation acquisition. The facility, closed on September 3, 2025, replaces a previous Wells Fargo promissory note with more favorable terms.
The credit facility features an interest rate of SOFR plus 3% (currently under 7.5%) and a two-year term. This financing supports the $16.5 million Medsphere acquisition, of which $8.25 million was paid at closing from internal cash flow. CareCloud plans to fully pay down the Medsphere-related obligation by mid-2026 through internally generated cash flow.
CareCloud (NASDAQ: CCLD) has raised its 2025 revenue guidance following the acquisition of Medsphere Systems Corporation's business assets. The company now projects 2025 revenue of $116-118 million, up from the previous guidance of $111-114 million. For 2026, CareCloud anticipates revenue of $128-130 million.
The improved outlook reflects increased scale and expanded participation in the hospital IT market, with growth driven by cross-selling opportunities, expanded hospital adoption, and continued AI innovation. While Adjusted EBITDA guidance remains unchanged, GAAP EPS will be impacted by higher non-cash amortization expense from the acquisition.